Skip to main content

North America Contributed Maximum Share to the Global In-Silico Drug Discovery Market in 2018

 

Drug discovery is used for the identification of the lead structure, which is followed by the synthesis of its analogs, and the latter’s screening to get candidate molecules for drug development. The objective of the drug discovery process is to search for new drug molecules that can bind to a specific target. Further, in the traditional drug discovery process, identifying the suitable drug target is the first and foremost task.

The different steps associated with the in-silico drug discovery process include target identification, target validation, lead identification, lead optimization, pre-clinical studies, and clinical trials. The market for in-silico drug discovery is focused on software, services, and artificial intelligence. Advanced software and informatics deliver far more insight than traditional methods, with a resolution significantly higher than ever before.

According to the market study published by BIS Research, the in-silico drug discovery market was estimated at $2,094.5 million in 2018 and is expected to grow at a CAGR of 12.92% during the forecast period 2019-2029.

The global in-silico drug discovery market was segmented on the basis of end-users, including contract research organizations (CRO), pharmaceutical industry, academic and research institutes, and other end users (hospitals and other care facilities).

Recently, in-silico drug discovery has gained a lot of popularity. The major reason for drug discovery’s popularity is the analysis of data generated from different technologies such as next-generation sequencing and non-invasive or minimally invasive diagnostic technologies. Due to the application of informatics, tools such as data semantics and visual analytics are being used in the industry. The usage of these tools has increased research effectiveness, improved predictability, and fostered effective teamwork among scientists. The pharmaceutical industry contributed the maximum share in 2018 and is expected to dominate the market share in the future as well.

In addition, as per the regional data of the in-silico drug discovery market, North America contributed the maximum to the market. However, it is the region of Asia-Pacific that is expected to grow with the highest CAGR during the forecast period from 2019 to 2029.

Labels

Labels:

Comments

Post a Comment

Popular posts from this blog

Chatbots Increasing Efficiency in Healthcare Market

Chatbots are one of the prominent technologies currently being integrated into the healthcare system. The chatbots are not considered as the SaMD (software as medical device) as they do not participate in clinical decision-making process, rather, they act as the personal healthcare assistant as well as the trainer for its users. Click Here To Get Detailed Description of  Chatbots in Healthcare Market The usage of chatbots in the healthcare has gained popularity since 2013, when Babylon Health, the first healthcare chatbot company of the U.K. was launched. The company offered symptom checker chatbot and has started using the same chatbot as a health checker as well. The industry comprises the bot developers, platform providers, content providers, and the interface providers. Since there are no regulatory bodies such as FDA and MHRA directly governing the usage of chatbots, launching the chatbot is convenient for the developers. New start-ups are coming up wit...
2 comments
Read more

Analyzing the Growth and Expansion of the Neurostimulation Devices Market

The global healthcare economic burden, at present, is primarily characterized by major contributors such as chronic pain and neurological disorders. The annual societal cost for chronic pain and neurological disorders accounted for $635 billion and $789 billion respectively in the U.S., in 2014. Opioids are one of the most preferred medicines for the treatment of chronic pain, however, the side-effects associated with opioids have resulted in a decline in their overall usage and sale. Consequently, the increasing cases of neurological disorders and the need for a novel approach for the treatment of such diseases has led to the advent of neuromodulation technologies. The rapid shift of the healthcare industry toward neurostimulation devices from opioids and other conventional treatment techniques can be attributed to the efficient, safe, and targeted approach of neurostimulation devices. BIS Research recently published a market intelligence report titled “ Global Neurostim...
Post a Comment
Read more

Tilt Rotor Aircraft Market Analysis & Forecast by 2031

The tilt rotor aircraft has been constantly evolving over the years, facing numerous technical difficulties, and had several accidents due to its complex structure and design; the latest technologies such as vectored thrust and ducted fans are being used widely to tackle this problem. Several companies have been trying to enter the market to leverage the market need and increase their market share at a global level by making strategic partnerships with key players and raising funds from venture capitalists. Several private start-ups such as Lilium GmbH, Joby Aviation, Kitty Hawk, Overair have already developed prototypes or are still in the research and development phase to use the advantages of tilt rotor technology for civilian applications such as urban air mobility, cargo, and logistics transportation, and others. Read Report Overview: https://bisresearch.com/industry-report/tilt-rotor-aircraft-market.html The tilt rotor aircraft are initially used in the military and d...
Post a Comment
Read more